Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Nyberg, Tommy; Nyberg, Tommy; M Ferguson, Neil; M Ferguson, Neil; G Nash, Sophie; H Webster, Harriet; Flaxman, Seth; Andrews, Nick; Hinsley, Wes; Lopez Bernal, Jamie; Kall, Meaghan; Bhatt, Samir; Blomquist, Paula; Zaidi, Asad; Volz, Erik; Abdul Aziz, Nurin; Harman, Katie; Funk, Sebastian; Abbott, Sam; Nyberg, Tommy; Nyberg, Tommy; M Ferguson, Neil; M Ferguson, Neil; G Nash, Sophie; H Webster, Harriet; Flaxman, Seth; Andrews, Nick; Hinsley, Wes; Lopez Bernal, Jamie; Kall, Meaghan; Bhatt, Samir; Blomquist, Paula; Zaidi, Asad; Volz, Erik; Abdul Aziz, Nurin; Harman, Katie; Funk, Sebastian; Abbott, Sam; Hope, Russell; Charlett, Andre; Chand, Meera; C Ghani, Azra; R Seaman, Shaun; Dabrera, Gavin; De Angelis, Daniela; M Presanis, Anne; Thelwall, Simon; Hope, Russell; Charlett, Andre; Chand, Meera; C Ghani, Azra; R Seaman, Shaun; Dabrera, Gavin; De Angelis, Daniela; M Presanis, Anne; Thelwall, Simon

doi:10.1016/s0140-6736(22)00462-7

Public

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Published in The Lancet • Mar 16, 2022

Authors:

Tommy Nyberg

Neil M Ferguson

Abstract

BACKGROUND: The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). We aimed to better characterise omicron severity relative to delta by ass...

Subject

Medicine

Cohort study

Cohort

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!